Publications by authors named "Alessandro Marinoni"
Article Synopsis
- X-linked agammaglobulinemia (XLA) is a primary immunodeficiency that leads to an increased risk of infections and chronic health issues, but long-term outcome data has been limited.
- A nationwide study in Italy followed 168 patients over an average of 8.35 years, revealing that symptoms like respiratory issues and chronic lung disease were common, while immunoglobulin therapy helped reduce severe infections.
- The study found that XLA patients had significantly lower overall survival compared to healthy individuals, particularly those with chronic lung complications, highlighting the need for improved management and physician awareness.
Immunostimulants in respiratory diseases: focus on Pidotimod.
Francesca Puggioni Magna Alves-Correia Manar-Farouk Mohamed Niccolò Stomeo Riccardo Mager Massimiliano Marinoni
Multidiscip Respir Med
November 2019
Usefulness of Pidotimod and its role as immunostimulant, has been discussed, we know, for several decades. Nevertheless, there is still much to know. Understanding its mechanisms and its potential usefulness in airway infections and its prevention, asthma both Th2 and non Th2 type, bronchiectasis, as adjuvant in vaccination and in allergen immunotherapy still remains to clearly unveil.
View Article and Find Full Text PDF